Shervin Korangy

Mr. Korangy is a seasoned executive with broad expertise, having more than 20 years of experience in investing and operating roles across a wide range of industries. He currently serves as the President and CEO of BVI Medical, Inc., a leading global developer, manufacturer, and marketer of surgical devices for the ophthalmic marketplace. Prior to this, he served as the CFO and Chief Strategy Officer of BVI. Prior to his appointment at BVI, Mr. Korangy was a senior executive at Novartis Group AG (NYSE: NVS), where he served as the Global Head of Corporate Finance. At Novartis, he ran multiple international geographies for the Alcon Division. Prior to joining Novartis in 2010, Mr. Korangy served as a Managing Director at The Blackstone Group (NYSE: BX), where he spent approximately 15 years in the firm’s restructuring and private equity businesses. He currently serves on the Board of Directors of BVI Holdings Ltd and The Hain Celestial Group (NASDAQ: HAIN) and has previously served on several other public and private corporate boards.